Advertisement

Topics

Generon (Shanghai) Corporation Ltd. Company Profile

11:59 EDT 24th March 2019 | BioPortfolio

Generon (Shanghai) Corporation Ltd. is a biotechnology company based in China with a mission to develop innovative biological therapies for patients in China and around the world. F-627 is a newer generation recombinant human granulocyte colony-stimulating factor (G-CSF) that helps the cancer patients to recover from chemotherapy induced neutropenia, a potentially life threatening condition. In addition to F-627, its most advanced development candidate, Generon has several other drug candidates in various developmental stages. The most noticeable is F-652, a first-in-class anti-inflammation candidate, will enter Phase I clinical development this year.


News Articles [390 Associated News Articles listed on BioPortfolio]

Generon to Start China Phase I Trial of IO Drug in B Cell Malignancies

Generon (Shanghai) has been approved to start a China Phase I clinical trial for A-319, a bi-specific antibody, in patients with B cell malignancies. A-319, Generon’s second bispecific antibody ...

Generon reports positive data from breast cancer drug trial

Generon BioMed has reported positive results from a Phase III trial of F-627 for the treatment of women with breast...Read More... The post Generon reports positive data from breast cancer drug trial ...

Generon Receives Investigative New Drug (IND) Approval from China SFDA for A-319 to Treat Patients with B Cell Malignancies

Generon Corporation, a leading biopharmaceutical company in China, today announced it received approval for the Company’s Investigational New Drug (IND) application from ...

Hortiflorexpo IPM Shanghai 2019, a Feast of Flowers, Horticulture and the Garden Industry

SHANGHAI, Sept. 15, 2018 /PRNewswire/ --The 21st Hortiflorexpo IPM Shanghai, managed by Shanghai Intex Exhibition Co.,Ltd, will be held from April 20-22, 2019 at Shanghai Read more...

Generon Presented Positive Phase III Results From a Double-Blind, Placebo Controlled-Clinical Trial of F-627 in Women with Breast Cancer Receiving Myelotoxic Chemotherapy

F-627 significantly reduced the duration and incidence of severe, and febrile, neutropenia Generon BioMed Holding Ltd. (Generon), announced today at the annual San Anto...

Generon Presented Pre-Clinical Immunotherapy Results With CD3-Activating Bi-Specific Antibody Targeting CD19 on B Cells in Mono- and Bi-Valent Format

A-319 and A-329 immunotherapies may prove beneficial in patients with B cell malignancies with less frequent dosing and lower cytokine inductions December 3rd, 2018, Sh...

Shanghai Intex Exhibition to Host Hortiflorexpo IPM Shanghai 2019

SHANGHAI, Dec. 1, 2018 /PRNewswire/ -- From April 20-22, 2019, Hortiflorexpo IPM Shanghai, the flower and horticulture expo, will be hosted by Shanghai Intex Exhibition Read more...

Maison Shanghai 2018: Raised to New Height of Lifestyle Industry

SHANGHAI, Oct. 29, 2018 /PRNewswire/ -- Maison Shanghai 2018, hosted by Shanghai UBM Sinoexpo Int'l Exhibition Co., Ltd., had a successful conclusion on 14 September Read more...

PubMed Articles [79 Associated PubMed Articles listed on BioPortfolio]

GIS-based method to delimit spheres of influence for a medical consortium: Experience of a pediatric medical consortium, Shanghai.

To improve the utilization efficiency of health care services, the concept of a "regional medical consortium" has attracted more attention during the most recent round of health care reform in China. ...

Seatbelt wearing rate in a Chinese city: Results from multi-round cross-sectional studies.

Road traffic crashes impose a heavy burden in China's most populous city, Shanghai. Since early 2016, Shanghai police have started deploying high-resolution cameras and an object-detection algorithm i...

Fluoroquinolone Resistance Mechanisms in Shigella Isolates in Shanghai, China Between 2010 and 2015.

This study aimed to investigate the antimicrobial susceptibility of Shigella isolated in Shanghai, China and to determine the genetic basis of its resistance to fluoroquinolones.

Microbial Etiology and Prognostic Factors of Ventilator-associated Pneumonia: A Multicenter Retrospective Study in Shanghai.

The microbial etiology and mortality risk factors of ventilator-associated pneumonia (VAP) have not been investigated extensively in Shanghai.

Future of cancer incidence in Shanghai, China: Predicting the burden upon the ageing population.

The age-specific cancer patterns have changed significantly over the last few decades in urban Shanghai. Predicting the cancer incidence in an ageing population can help to anticipate future resource ...

Clinical Trials [81 Associated Clinical Trials listed on BioPortfolio]

Shanghai Cohort Study of Diabetic Eye Disease

To describe the design, methodology and baseline characteristics of the Shanghai Cohort study of Diabetic Eye disease (SCODE) study, a community-based study to determine the prevalence and...

Peer Support To Enhance The Shanghai Integration Model Of Diabetes Care: Extension & Dissemination

This project will develop a combined model of the Shanghai Integration Model and peer support, implement and evaluate it in ten Community Health Centers in Shanghai, disseminate the result...

Shanghai Epidemiology Study for Adolescents and Children With Cancer

The purpose of this study is to describe the morbidity, mortality, disability and survival rate in Shanghai adolescents and children with cancer diagnosed since January 2002.

Epidemic Profile of Left Ventricular Diastoic Dysfunction in the Community Elderly and Establishing Prediction Model: the Northern Shanghai Study

This study is one of the largest ongoing prospective population studies to evaluate target organ damages (TODs) and Left Ventricular Diastoic Dysfunction in the community-dwelling elderly ...

Progression of Hematopoietic Diseases in Shanghai, China

The purpose of this study is to identify and characterize blood diseases presenting at Shanghai hospitals and to compare them with respect to clinical presentation, phenotype, molecular ch...

Companies [299 Associated Companies listed on BioPortfolio]

Generon Corporation

Generon (Shanghai) Corporation (Generon) is a leading biotech company located in China focusing on development of innovative biological therapies for global patients. For more inf...

Generon (Shanghai) Corporation Ltd.

Generon (Shanghai) Corporation Ltd. is a biotechnology company based in China with a mission to develop innovative biological therapies for patients in China and around the world....

Generon BioMed Holding Ltd.

Generon BioMed Holding Ltd. is a privately held and leading Biotechnology Company located in Shanghai, China focusing on the development of innovative biological therapies for pat...

Generon BioMed Holding Ltd

Generon BioMed Holding Ltd is a privately held and leading biotechnology company located in Shanghai, China focusing on the development of innovative biological therapies for pati...

Shanghai Sundise Traditional Chinese Medicine Co., Ltd.

Shanghai Sundise Traditional Chinese Medicine Co., Ltd. is a technology corporation specialized in the modernization of Traditional Chinese Medicine, based in Shanghai, China. Sun...

More Information about "Generon (Shanghai) Corporation Ltd." on BioPortfolio

We have published hundreds of Generon (Shanghai) Corporation Ltd. news stories on BioPortfolio along with dozens of Generon (Shanghai) Corporation Ltd. Clinical Trials and PubMed Articles about Generon (Shanghai) Corporation Ltd. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Generon (Shanghai) Corporation Ltd. Companies in our database. You can also find out about relevant Generon (Shanghai) Corporation Ltd. Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Biotechnology
Antibodies Antisense Assays Biochips Bioinformatics Biological Therapy Biomarkers Biomaterials Bioscience Cell Culture Cloning Cytokine Diagnostics Dna Extraction Dna Sequencing Dna Transform...

Biological Therapy
Biological therapy involves the use of living organisms, substances derived from living organisms, or laboratory-produced versions of such substances to treat disease. Some biological therapies for cancer use vaccines or bacteria to stimulate the body&rs...

Cancer
  Bladder Cancer Brain Cancer Breast Cancer Cancer Cervical Cancer Colorectal Head & Neck Cancers Hodgkin Lymphoma Leukemia Lung Cancer Melanoma Myeloma Ovarian Cancer Pancreatic Cancer ...


Corporate Database Quicklinks



Searches Linking to this Company Record